Evidence map›Paper›PMID 41281643›Full record

ArticleMaterials today. Bio2025

"AND" or "OR" logic operations of DNA probes: Fluorescent detection and discrimination of ovarian cancer cells via dual-microRNA in complex environments.

Guanghui Wang, Yuting Li, Shuangjie Liu, Jing Li, Meizhen Yao, Jiaxiang Cheng, Ting Chen, Jia Zhang, Fenglei Gao, Wensheng Du and 1 more

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guanghui WangDepartment of Obstetrics and Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.
Yuting LiJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
Shuangjie LiuDepartment of Obstetrics and Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.
Jing LiDepartment of Obstetrics and Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.
Meizhen YaoDepartment of Obstetrics and Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.
Jiaxiang ChengDepartment of Obstetrics and Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.
Ting ChenDepartment of Obstetrics and Gynecology, Suining People's Hospital, Xuzhou, Jiangsu, 221200, China.
Jia ZhangDepartment of Obstetrics and Gynecology, Suining People's Hospital, Xuzhou, Jiangsu, 221200, China.
Fenglei GaoJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
Wensheng DuDepartment of Obstetrics and Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.
Lei HuaDepartment of Obstetrics and Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of DNA logic circuits has enabled novel signal carriers for the identification of cancer cells. Addressing the limitations of single-target detection in ovarian cancer, including insufficient specificity and signal delay, this study innovatively constructs a dual-miRNA detection system based on "AND" or "OR" logic operations. In the "AND" logic pathway, both miR-221 (LOD is 0.1792 nM) and miR-96 (LOD is 0.1990 nM) are required to cooperatively trigger strand displacement amplification (SDA) for fluorescence signal activation. In contrast, the "OR" logic pathway enables signal output through either miR-221 or miR-96 (LODs are 0.1020 nM and 0.056 nM, respectively), significantly enhancing sensitivity for low-abundance samples. The core innovation lies in the hairpin structure-mediated miRNA recycling mechanism, where competitive binding allows target molecules to repeatedly participate in reactions, thereby amplifying signal efficiency. This strategy demonstrates high specificity in SKOV3 cells, and its modular design enables rapid adaptation to other miRNA combinations (e.g., miR-21/miR-155) through DNA sequence reprogramming, offering a versatile platform for multi-tumor subtyping. The approach provides new perspectives for intelligent, portable biosensing and bioanalytical applications.

Indexed as

DNA logic gateFluorescence detectionIdentification of ovarian cancer cellsmiRNA detection

Identifiers

PMID41281643
PMCPMC12630042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.